Hillary Clinton

Sydney Grammar students, under the supervision of the University of Sydney and global members of the Open Source Malaria consortium, have reproduced an essential medicine in their high school laboratories. The drug, Daraprim, had been the subject of controversy when the price was hiked from US$13.50 to US$750 a dose last year. Daraprim - originally used as an antimalarial after its synthesis by Nobel Prize winner Gertrude Elion - is now more widely used as an anti-parasitic treatment for toxoplasmosis, which can be a dangerous disease for pregnant women and people with compromised immune systems, such as those living with HIV or AIDS...

Read More »

The State Department’s communications system is operating without basic technical security measures in place, despite warnings about its vulnerabilities, according to documents obtained by BuzzFeed and sources who have worked on the project. [...] Read More »

Taking the podium in the U.S. Department of State’s Ben Franklin Room one last time before stepping down on Feb. 1, Secretary of State Hillary Clinton thanked a lot of people, offered reminiscences, and announced a flurry of last-minute programs.[...] One of those new programs, the Alliance for an Affordable Internet, barely got a mention in Clinton’s speech. But it merits attention. Read More »

Todd Park, Chief Technology Officer at the White House, gave the audience at the 2012 Social Good Summit on Saturday a high-energy lesson in the importance of making government data more useful and available to anyone. Read More »

New initiative to provide free, open access, high-quality education materials in Arabic, with a focus on science and technology. Read More »

The Senate Foreign Relations Committee on Wednesday unanimously approved a resolution calling on the United States to prevent the United Nations from having a greater role in governing the Internet. Read More »

Don Reichmuth survived prostate cancer once before, back in 2007, so his physician was concerned when tests recently revealed the cancer had returned. Reichmuth's physician prescribed a drug called enzalutamide, marketed by the Japanese company Astellas Pharma, Inc. under the brand name Xtandi. But when the physician sent the prescription to the pharmacy, the managers of Reichmuth's insurance plan sent back an immediate refusal to approve it. Reichmuth, a retired teacher who lives in Washington State, was puzzled by the logic. Then he learned the price of the Xtandi prescription: over $9,700 each month...

Read More »